tiprankstipranks
Trending News
More News >
SLR Investment Corp. (SLRC)
NASDAQ:SLRC
US Market

SLR Investment Corp. (SLRC) Earnings Dates, Call Summary & Reports

Compare
488 Followers

Earnings Data

Report Date
May 13, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.4
Last Year’s EPS
0.41
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasizes strong portfolio quality, disciplined underwriting, robust origination momentum (notably in ABL), solid liquidity, and attractive returns relative to peers. Key weaknesses include yield compression due to lower base rates, tight spreads in sponsor finance, and elevated repayments that created timing variability. Management presents confidence in their defensive positioning, available capital to act on opportunities, and ongoing pipeline activity.
Company Guidance
Management's guidance was to remain disciplined yet opportunistic in 2026: the Board declared a Q1 2026 base distribution of $0.41 per share (payable 03/27/2026, record 03/13/2026), and the company has >$850M of available capital (including SSLP capacity) with roughly $55M undrawn at SSLP; debt outstanding is ~$1.2B with net debt-to-equity of 1.14x, no near-term unsecured note maturities until December 2026, and room to increase leverage toward the high end of its target (1.25x) if attractive opportunities arise. They expect to deploy into specialty finance where origination momentum persists (Q4 originations $462M, FY originations $1.84B, net funding in Q4 $70M, comprehensive portfolio $3.3B, annual growth 7.2%), with continued emphasis on ABL (Q4 ABL originations ~$247M, FY ABL ~$1.1B; ABL all‑in ~SOFR+600, ABL yield 12.6%), equipment finance (~$1.1B, yield ~11%), life sciences (first‑lien commitments ~$500M in 2025; portfolio ~$180M, yield 12.3%), and selective cash‑flow lending (~$475M, ~15% of portfolio, yield just under 10%, borrower EBITDA ~$100M, LTV ~40%, interest coverage 2.3x). Key credit and capital metrics underpinning the guidance: NAV $18.26/share, Q4 NII $0.40/share, Q4 net income $0.46/share (10.1% annualized ROE), FY net income $1.70/share (9.3% ROE), weighted average portfolio yield 11.6% (down from 12.2% Q3), ~95% first‑lien and ~98% senior secured by fair value, 100% performing, ~2% software exposure, and PIK income de minimis (~1–2%); management reiterated low sensitivity to base‑rate declines and a plan to prudently access unsecured debt markets.
Steady Earnings and Returns
Q4 net investment income (NII) of $0.40 per share (flat QoQ) and net income of $0.46 per share; Q4 net income annualized return on average equity of 10.1%. Full-year 2025 net income of $1.70 per share representing a 9.3% return on average equity.
Portfolio Growth and Scale
Comprehensive portfolio of $3.3 billion at year-end with annual growth of 7.2% and average exposure per borrower of $3.8 million.
Strong Origination Momentum
Q4 originations of $462 million (second-highest on record), up 36% year-over-year and 3% quarter-over-quarter; full-year originations of $1.84 billion.
Shift to Asset-Based Specialty Finance
More than 83% of portfolio in senior secured specialty finance loans (highest percentage in 20-year history); ABL originations of $247 million in Q4 (almost double prior-year period) and $1.1 billion for the year (nearly double 2024).
High Credit Quality and Low Problem Loans
Approximately 95% of comprehensive portfolio in first lien senior secured loans; 100% of investments at cost performing with zero non-accruals; PIK income de minimis (~1–2% of total income depending on metric cited).
Attractive Yields Across Key Verticals
Weighted average portfolio yield of 11.6% (Q4); ABL asset-level weighted average yield 12.6%; life science first-lien weighted average yield 12.3%; equipment finance weighted average yield ~11%.
Strong Liquidity and Funding Profile
Over $850 million of available capital to deploy (including credit facility capacity and specialty finance capacity); approximately $1.2 billion of debt outstanding with net debt-to-equity of 1.14x (within target range); next unsecured note maturity in December 2026; investment-grade ratings from Fitch, Moody's and DBRS.
Successful Liability Management
Refinanced SSLP revolving facility reducing spread by 75 basis points (from SOFR+2.90% to SOFR+2.15%); improved borrowing flexibility, advance rates and extended maturities.
Shareholder-Friendly Actions and Alignment
Board declared Q1 2026 quarterly base distribution of $0.41 per share; management and SLR team own over 8% of the company and significant incentive compensation is invested in SLR stock; dividend yield ~11.2% at recent market close.
Diversification and Defensive Positioning
Very low direct exposure to software (~2% of portfolio) and concentrated emphasis on asset-backed strategies (ABL, equipment finance, life sciences) designed for downside protection and active collateral monitoring.

SLR Investment Corp. (SLRC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SLRC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
0.40 / -
0.41
Feb 24, 2026
2025 (Q4)
0.40 / 0.40
0.44-9.09% (-0.04)
Nov 04, 2025
2025 (Q3)
0.41 / 0.40
0.40.00% (0.00)
Aug 05, 2025
2025 (Q2)
0.40 / 0.40
0.43-6.98% (-0.03)
May 07, 2025
2025 (Q1)
0.41 / 0.41
0.44-6.82% (-0.03)
Feb 25, 2025
2024 (Q4)
0.43 / 0.44
0.440.00% (0.00)
Nov 06, 2024
2024 (Q3)
0.43 / 0.40
0.43-6.98% (-0.03)
Aug 07, 2024
2024 (Q2)
0.43 / 0.43
0.422.38% (+0.01)
May 08, 2024
2024 (Q1)
0.43 / 0.44
0.417.32% (+0.03)
Feb 27, 2024
2023 (Q4)
0.43 / 0.44
0.417.32% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SLRC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 24, 2026
$14.65
Nov 04, 2025
$14.98$15.12+0.93%
Aug 05, 2025
$15.13$15.63+3.30%
May 07, 2025
$14.33$14.49+1.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does SLR Investment Corp. (SLRC) report earnings?
SLR Investment Corp. (SLRC) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
    What is SLR Investment Corp. (SLRC) earnings time?
    SLR Investment Corp. (SLRC) earnings time is at May 13, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SLRC EPS forecast?
          SLRC EPS forecast for the fiscal quarter 2026 (Q1) is 0.4.